Skip to main content
. Author manuscript; available in PMC: 2021 May 13.
Published in final edited form as: Nano Lett. 2020 May 4;20(5):4051–4058. doi: 10.1021/acs.nanolett.0c01654

Figure 1.

Figure 1.

Cell membrane-coated uricase-loaded MOF nanoparticles for the enzymatic degradation of uric acid. To fabricate the formulation, MOF-uricase cores are generated by mixing the enzyme payload with Zn2+ and 2-methylimidazole (mim), followed by coating with natural cell membrane derived from source cells such as RBCs or MΦs. The resulting membrane-coated MOF-uricase nanoparticles effectively convert uric acid into allantoin, which can help to manage conditions such hyperuricemia and gout.